Clinical Trial Update: Biotin-Acridine Red Cell Exchange Kinetics [Phase 2]

View source ↗

Summary

A Phase 2 trial of Biotin-Acridine for sickle cell disease has been withdrawn. The study was sponsored by Cerus Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Biotin-Acridine

Snippet

Sponsor: Cerus Corporation | Conditions: Sickle Cell Disease | Phase 2 | Status: WITHDRAWN